FA2H and fatty liver disease: In the acute phase of fatty liver disease, Ji et al. found that EVs derived from HCs express miR-3075, which inhibits fatty acid 2-hydroxylase (FA2H), an enzyme responsible for the hydroxylation of free fatty acids, and enhances the hepatocyte insulin sensitivity in vivo.